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Structural genomic variations represent a major
driving force of evolution, and a burst of large
segmental gene duplications occurred in the human
lineage during its separation from nonhuman
primates. SRGAP2, a gene recently implicated in
neocortical development, has undergone two
human-specific duplications. Here, we find that both
duplications (SRGAP2B and SRGAP2C) are partial
and encode a truncated F-BAR domain. SRGAP2C
is expressed in the developing and adult human
brain and dimerizes with ancestral SRGAP2 to
inhibit its function. In the mouse neocortex, SRGAP2
promotes spine maturation and limits spine density.
Expression of SRGAP2C phenocopies SRGAP2
deficiency. It underlies sustained radial migration
and leads to the emergence of human-specific
features, including neoteny during spine maturation
and increased density of longer spines. These results
suggest that inhibition of SRGAP2 function by
its human-specific paralogs has contributed to the
evolution of the human neocortex and plays an im-
portant role during human brain development.
INTRODUCTION
In recent years, many potential genetic mechanisms have been
proposed to participate in human brain speciation. These
include changes in transcriptional regulation (Enard et al.,
2002; Konopka et al., 2009), accelerated evolution of small
noncoding RNAs (Pollard et al., 2006), changes in the activity
and/or region-specificity of enhancer elements (McLean et al.,2011; Prabhakar et al., 2006, 2008) or changes in patterns of
alternative splicing (Calarco et al., 2007). So far, very few studies
have assessed the functional consequences of these changes.
Another important mechanism is genomic duplication, which
generates copies of genetic material that serve as substrates
formolecular evolution (Hurles, 2004; Ohno, 1970). In fact, recent
lines of evidence have revealed that a burst of large segmental
gene duplications occurred in the human lineage during its
separation from nonhuman primates approximately 6 million
years ago (Bailey et al., 2002; Fortna et al., 2004). Several of
the genes contained in these duplications are expressed in
the developing brain. This has led to the hypothesis that these
evolutionarily recent gene duplications might have participated
in the emergence of human-specific features of brain develop-
ment and function (Bailey and Eichler, 2006; Sikela, 2006;
Stankiewicz and Lupski, 2010; Varki et al., 2008). However,
this hypothesis has never been tested experimentally. The prin-
cipal obstacles have been that the function of the ancestral
genes is often unknown and that the duplications are poorly
assembled in the current human genome because of their high
degree of conservation with the ancestral gene.
In this study, we focused on SLIT-ROBO Rho-GTPase-
activating protein 2 (SRGAP2), a gene highly expressed during
brain development (Bacon et al., 2009; Guerrier et al., 2009).
The protein SRGAP2 is composed of three functional domains
(Guerrier et al., 2009): an N-terminal F-BAR (Bin, Amphiphysin,
Rvs) domain (Itoh et al., 2005) involved in membrane deforma-
tion, a central Rho GTPase-Activating Protein (Rho-GAP)
domain that specifically stimulates the GTPase activity of
Rac1, and a C-terminal tail containing an SH3 domain. We
previously demonstrated that SRGAP2 controls cortical neuron
migration (Guerrier et al., 2009). Recent analysis of large
segmental duplications has revealed that SRGAP2 has two
main duplicates in the Homo neanderthalensis and Homo
sapiens genomes, but not in the genome of our closest livingCell 149, 923–935, May 11, 2012 ª2012 Elsevier Inc. 923
relatives, the chimpanzee, orangutan and gorilla (Sudmant et al.,
2010). In this study, we mapped the location and genomic struc-
ture of the human-specific SRGAP2 paralogs (see also accom-
panying article by Dennis et al. [2012] in this issue of Cell). We
provide evidence that they are expressed in human neurons
and encode a truncated F-BAR domain that interacts with
ancestral SRGAP2 to inhibit its function. We used in vitro and
in vivo approaches to determine the function of SRGAP2 and
its human paralogs in the neocortex region of the brain, the
evolution of which is thought to underlie the emergence of
human cognitive abilities. Our results uncover a new function
for ancestral SRGAP2 in promoting dendritic spine maturation
and indicate that expression of a human-specific paralog of
SRGAP2 in mouse pyramidal neurons extends the phase of
spine development and leads to an increased density of longer
spines in vivo, a feature characterizing pyramidal neurons in
the human neocortex (Benavides-Piccione et al., 2002; Elston
et al., 2001).
RESULTS
Genomic Organization of SRGAP2 Paralogs
The gene SRGAP2 was identified by using array comparative
genomic hybridization (aCGH) as having undergone human-
specific duplication, resulting in extra copies in the H. sapiens
genome, but not in the genomes of four nonhuman primates
(Fortna et al., 2004). However, the number and locations of these
human-specific copies were unknown. Using the Blast-Like
Alignment Tool (BLAT), we searched the GRCh36/hg18 refer-
ence genome (available human genome assembly in 2006 at
the start of the project) with the cDNA of human SRGAP2 (Gen-
Bank BC132874.1). We located the ancestral SRGAP2 gene at
chromosome 1q32.1 (SRGAP2A) and two duplicates at 1q21.1
and 1p12 (hereafter referred to as SRGAP2B and SRGAP2C,
respectively) that showed more than 99% similarity to the query
sequence (Figures S1A and 1B available online). The observation
that there are two duplicates of SRGAP2 in the human genome
was recently confirmed and validated by analysis of copy
number variation in whole-genome shotgun sequencing data
(Sudmant et al., 2010). Even in the most recent reference
assembly (GRCh37/hg19), the ancestral SRGAP2A gene is clas-
sified as misassembled, and SRGAP2B and SRGAP2C lie in
recently duplicated regions of the genome that are incompletely
assembled and present large contig gaps. In order to determine
the approximate genomic organization of these three paralogs,
we retrieved human bacterial artificial chromosome (BAC) clones
mapping to these three loci. To fill in the gaps in the assembled
sequence, we performed BLAST searches against the end
sequences database by using genome sequences flanking the
gaps as inputs. The exon organization of the human BACs was
determined by dot blot hybridization with several probes
covering different portions of the entire extent of SRGAP2
cDNA (data not shown). In addition, exons in each BAC clone
were sequenced from the human BACDNA either directly before
or following amplification to reveal the organization of the three
SRGAP2 paralogs (data not shown, Figure S1C). The full
sequencing and assembly of the three genomic loci and their
recent evolution is the focus of the accompanying paper by924 Cell 149, 923–935, May 11, 2012 ª2012 Elsevier Inc.Dennis et al. (2012). Both analyses revealed that SRGAP2A
contains 22 exons and encodes a protein with 1,071 amino acids
(aa), which is 98% identical to its mouse ortholog SRGAP2,
whereas SRGAP2B and SRGAP2C have a 30 breakpoint located
in intron 9 of the ancestral copy and are predicted to express
a protein containing 459 aa. The first 452 aa correspond to the
first 452 aa of the F-BAR domain of SRGAP2A (aa1-501; Guerrier
et al., 2009). Because intron 9 of SRGAP2A becomes 30 untrans-
lated region (30 untranslated region [UTR]) in SRGAP2B and
SRGAP2C, both use an alternate stop codon located in intron
9, which adds 7 aa (VRECYGF; Figure 1A). We identified two
potential polyadenylation sites in the 30 UTRs of SRGAP2B and
SRGAP2C based on the clustering of expressed sequence
tags (EST) from the database of Expressed Sequence Tags
(dbEST). The two 30 UTRs are 1.4 kb or 5 kb long. Taken
together, our results indicate that both paralogs encode a trun-
cated F-BAR domain that lacks the last C-terminal 49 aa.
Expression of SRGAP2 Paralogs
We isolated one cDNA clone from a human library (GenBank
BC112927.1) originating from SRGAP2C that is almost identical
in sequence to the first 9 exons of the ancestral SRGAP2A,
except for five nonsynonymous base pair mutations (out of
1,356 base pairs) mutating five arginine (5R) residues (Figure 1A).
As shown in the accompanying paper by Dennis et al. (2012),
SRGAP2B and SRGAP2C are identical apart from a few base
pair mutations, and both lack the last 49 aa of the F-BAR domain.
In order to determine the expression of these human-specific
paralogs in the brain, we took advantage of the fact that intron
9 becomes 30 UTR in SRGAP2B and SRGAP2C to perform
in situ hybridization (ISH) on cryostat sections from human fetal
cortex (gestational week [GW] 11). SRGAP2B and SRGAP2C
were therefore detected using an intron 9 probe that does not
recognize processed mRNA encoding ancestral SRGAP2A,
whereas SRGAP2A was detected using an exon 22 probe that
conversely does not recognize SRGAP2B or SRGAP2C (Figures
1A and 1B and data not shown). This analysis revealed a striking
similarity in the pattern of expression of the paralogs in the
germinal layers (ventricular zone [VZ] and subventricular zone
[SVZ]), in which neural progenitors divide to produce postmitotic
neurons. We also detected significant expression in the cortical
plate (Figure 1B), in which neurons end their migration and
undergo terminal differentiation and synapse formation. To refine
this gene expression analysis, we took advantage of the possi-
bility to differentiate human embryonic stem cells (hESCs) into
relatively pure populations of forebrain excitatory pyramidal
neurons (Kim et al., 2011). Total RNA was harvested from hESCs
at different time points during their directed differentiation in vitro
(Kim et al., 2011), allowing us to perform a temporal analysis
using reverse-transcriptase PCR (RT-PCR) primers (Figure 1C
and Table S1), amplifying SRGAP2A (exon 10-11 junction) or
SRGAP2B and SRGAP2C (intron 9) transcripts. Both ancestral
and human-specific paralogs of SRGAP2 were detected at low
levels in undifferentiated hESCs that express OCT4 (lane 1
in Figure 1C). Their expression increased in a mixture of neural
progenitor cells (PAX6+) and immature neurons (TUJ1) (3 weeks
in culture [wic], Kim et al., 2011; lane 2 in Figure 1C) as well
as in more mature, synaptically active, PSD95-expressing
Figure 1. SRGAP2 and Its Human-Specific Paralogs Are Expressed in Human Neurons
(A) Schematic representation of transcripts of the three paralogs of SRGAP2. SRGAP2B and SRGAP2C encode a truncated F-BAR domain with nonsynonymous
mutations marked in red. VRECYGF denotes C-terminal aa residues translated from intron 9 that are unique to SRGAP2B and SRGAP2C.
(B) RNA in situ hybridization on developing human cortex at GW 11 using probes specific for SRGAP2B and SRGAP2C (intron 9) and SRGAP2A (exon 22). Cresyl
violet marks the cortical layers: VZ (ventricular zone), SVZ (subventricular zone), IZ (intermediate zone), CP (cortical plate), and MZ (marginal zone).
(C) RT-PCR showing that SRGAP2A, SRGAP2B, and SRGAP2C are expressed in OCT4+ hESCs, neurons derived from hESCs following 3 wic (PAX6+, PSD95-)
or 5 wic (PSD95+), as well as fetal human brain (F.h.br) and adult human brain (Ad.h.Br).
(D) RT-PCR performed on RNA from fetal (f.) human brain, adult (Ad.) human brain and adult chimpanzee (Ad. Chimp) brain samples.SRGAP2A primers detect the
ancestral copy in human and chimp samples. SRGAP2C primers show an amplification band specifically in the human samples, indicating stringency of primer
hybridization only to the SRGAP2C variant.
(E) qRT-PCR showing relative abundance of SRGAP2C and SRGAP2A in samples corresponding to lanes 1, 2, and 3 in (C) normalized to levels of GAPDH (mean
±SD; standard deviation from two technical replicates).
(F) Full-length SRGAP2A detected by western blotting with anti (a)-SRGAP2 N-terminal or anti-SRGAP2 C-terminal when transfected in HEK293T cells (grey
arrowhead). The anti-SRGAP2 N-terminal, but not the anti-SRGAP2 C-terminal, can detect SRGAP2C (red arrowhead).
(G) A translation product corresponding to the human-specific paralogs SRGAP2B or SRGAP2C in size (50 kDa; red arrowhead) is detected (1) in human cell
lines SH-SY5Y and MCF7, but not in mouse developing cortex or cell line NIH3T3 and (2) only upon western blotting with anti-SRGAP2 N-terminal, not with anti-
SRGAP2 C-terminal.
(H) Western blotting with anti-SRGAP2 N-terminal showing knockdown of endogenous SRGAP2B or SRGAP2C, but not ancestral SRGAP2A, by siRNA against
intron 9 (si-intron9-1 and -2; lane 2 and 3) in SH-SY5Y cells. See also Figure S1 and Table S1.
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hESC-derived neurons (5 wic; Kim et al., 2011; lane 3 in Fig-
ure 1C). Both transcripts were also detected using RT-PCR
from unpooled mRNA isolated from an individual human fetal
brain (GW16; lane 4 in Figure 1C) and from the brain of a 44-
year-old adult human (lane 5 in Figure 1C). In order to compare
the relative level of expression of transcripts encoded by the
paralogs and to tease apart transcripts derived from SRGAP2B
and SRGAP2C, we took advantage of a fixed single base pair
variation in exon 6 ofSRGAP2C to design a set of primers specif-
ically amplifying SRGAP2C transcripts (but not chimpanzee or
human SRGAP2A transcripts or human SRGAP2B transcripts;
Table S1 and Figure 1D). Quantitative-RT-PCR (qRT-PCR)
revealed that both SRGAP2C and SRGAP2A transcripts were
abundant in hESC-derived neurons that were cultured for 3
and 5 weeks, compared to undifferentiated hESCs (Figure 1E).
However, SRGAP2C transcript maintained a higher level
of expression than SRGAP2A after 5 wic (Figure 1E). This
suggests that SRGAP2C and SRGAP2A transcripts do not
systematically covary and might be under different regulatory
mechanisms, leading to different transcript abundance in human
neurons.
We next wanted to determine whether a protein product
corresponding to the translation of SRGAP2B or SRGAP2C
transcripts could be detected in human cells. In transfected
HEK293T cells, which do not express endogenous SRGAP2,
SRGAP2A could be detected in a western blot using an antibody
directed against either the C-terminal (aa873-890) or the
N-terminal (aa193-205) domain of the protein (Figure 1F, gray
arrow). As predicted, SRGAP2C was detected as a single band
of a lower molecular weight only by using the antibody directed
against the N-terminal of SRGAP2 (Figure 1F, red arrow). In the
human SH-SY5Y neuroblastoma cell line and the human MCF7
breast cancer cell line, a 120 kDa protein corresponding to
SRGAP2A (Figure 1G, grey arrow) and a 50 kDa protein (red
arrow) were detected with the N-terminal SRGAP2 antibody.
The 50 kDa product was not detected in the same lysates by
using the C-terminal SRGAP2 antibody, in lysates isolated
from postnatal day (P) 7 mouse cortex, or from the mouse
fibroblast NIH3T3 cell line, suggesting that it originates from
human-specific SRGAP2B or SRGAP2C (Figure 1G). We
confirmed that the 50 kDa protein product detected with the
N-terminal SRGAP2 antibody in neuroblastoma SH-SY5Y cells
was specifically translated from SRGAP2B or SRGAP2C by
using two independent small interfering RNAs (siRNAs; called
siRNA intron9-1 and intron9-2) targeting intron 9, i.e., the 30
UTR of the endogenous SRGAP2B and SRGAP2C mRNA that
is absent in endogenous SRGAP2A mRNA (lanes 2 and 3 in
Figure 1H). The 50 kDa protein product was detected in human
SH-SY5Y cells transfected with control scramble siRNA, but
not in cells transfected with siRNA intron9-1 or intron9-2 (Fig-
ure 1H). Overall, our results demonstrate that SRGAP2A and
its human-specific paralog SRGAP2C are expressed in fetal
and adult human brains and neurons.
SRGAP2C Interacts with and Inhibits Ancestral SRGAP2
In Vitro
Next, we explored the potential function of the human-specific
paralogs of SRGAP2. Because the F-BAR domain is a homodi-926 Cell 149, 923–935, May 11, 2012 ª2012 Elsevier Inc.merization domain involved in membrane deformation (Frost
et al., 2009), and because SRGAP2C encodes most of the
F-BAR domain of the ancestral SRGAP2A protein, we tested
whether it retained the ability to dimerize with full-length
SRGAP2. In HEK293T cells, hemagglutinin (HA)-tagged
SRGAP2C was coexpressed with either SRGAP2A-GFP or
SRGAP2C-enhanced green fluorescent protein (EGFP), followed
by HA immunoprecipitation. Our results showed that SRGAP2C
protein can dimerize with both SRGAP2A and SRGAP2C (Fig-
ure 2A). This suggests that the few aa substitutions in the
sequence of SRGAP2C, as well as the deletion of the last 49
aa, do not alter the ability of SRGAP2C to dimerize with full-
length SRGAP2A. In order to explore the biological function of
SRGAP2C protein, we employed a robust membrane deforma-
tion assay in COS7 cells (Guerrier et al., 2009). As previously
shown for mouse SRGAP2 (Guerrier et al., 2009), expression of
human SRGAP2A-EGFP induced filopodia protrusions in COS7
cells (Figures 2B, 2C, and 2L). In contrast, expression of
SRGAP2C-monomeric red fluorescent protein (mRFP) failed to
induce filopodia (Figures 2D and 2L). Furthermore, when coex-
pressed with ancestral SRGAP2A-EGFP, SRGAP2C-mRFP effi-
ciently blocked its ability to induce filopodia (Figures 2E and 2L).
Expressing a cDNA encoding SRGAP2B (clone provided by
Megan Dennis from E. Eichler’s laboratory) gave similar results
(Figures 2F, 2G, and 2L). Two features of SRGAP2C might
account for this ability to block SRGAP2A function: (1) the
mutation of several arginine residues that could mediate
membrane binding/deformation properties (Shimada et al.,
2007) and (2) the truncation of the F-BAR domain by deleting
the last 49 aa (see Figure 1A). To test the relative contribution
of these two duplicate-specific differences, we introduced
these mutations individually into the native F-BAR domain of
ancestral SRGAP2 (F-BAR-D5R and F-BAR-D49, respectively).
Although both mutations abolished the filopodia induction
properties of the F-BAR domain (Figures 2H, 2J, and 2L),
only F-BAR-D49 mimicked SRGAP2C with regard to its ability
to antagonize SRGAP2-mediated membrane protrusions
(Figures 2K and 2L). Combined with the observation that the
deletion of the most C-terminal 49 aa, but not the 5R mutations,
is a common feature of SRGAP2C and SRGAP2B, our data
suggest that both human-specific paralogs can interact with
ancestral SRGAP2A and inhibit its function.
SRGAP2C Inhibits SRGAP2 Function during Cortical
Neuron Migration
We then decided to test whether the human-specific duplicates
of SRGAP2 can also inhibit the documented function of SRGAP2
during cortical neuron migration (Guerrier et al., 2009). We
focused on SRGAP2C for further experiments because in the
human brain, SRGAP2C transcripts are substantially more
abundant than SRGAP2B transcripts (see accompanying paper
by Dennis et al. [2012]). We used in utero electroporation to
compare the in vivo function of SRGAP2 and its human-specific
paralog, SRGAP2C. Mouse cortical progenitors generating
layer 2/3 pyramidal neurons were electroporated at E14.5 and
analyzed at E18.5, which is when most control neurons have
exited the cell cycle, engaged radial migration, and a significant
portion have reached their final position in the cortical plate (CP).
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Figure 2. SRGAP2C Dimerizes with SRGAP2A and Inhibits Its Membrane Deformation Properties in COS7 Cells
(A) Coimmunoprecipitation (Co-IP) of SRGAP2A-EGFP or SRGAP2C-EGFP, along with HA-SRGAP2C in HEK293T cells, transfected with the indicated
constructs. Co-IP was performed using mouse anti-HA and mouse IgG as negative control. Western blotting was performed with a mouse (ms) anti (a)-GFP.
(B–K) Representative confocal images of COS7 cells transfected with indicated constructs and visualized by EGFP signal. Scale bar, 5 mm. Inset shows 2-fold
magnification.
(L) Box plot showing quantification of the number of filopodia per pixel along cell periphery for cells represented in (B–K). n = 20 cells per condition. ***p < 0.001,
Mann-Whitney test.As previously demonstrated for mouse SRGAP2 in ex vivo
electroporated slices of embryonic cortices (Guerrier et al.,
2009), overexpression of human ancestral SRGAP2A induced
excessive branching of the leading process (LP) of radially
migrating neurons compared to control (Figures 3A and 3B),
resulting in slower migration with less neurons accumulating in
the CP after 4 days in utero (Figures 3C and 3D). Conversely,
knockdown of SRGAP2 by using a short hairpin RNA (shRNA)
(Figure S2) resulted in a reduction of LP branches on migrating
neurons as compared to neurons expressing control shRNA
(Figures 3A and 3B), and this reduction has been shown to
increase the rate of migration (Guerrier et al., 2009). Interestingly,
neurons expressing SRGAP2C showed a reduction in LPbranching that was very similar to that seen after SRGAP2
knockdown (Figures 3A and 3B), which results in an increased
rate of radial migration as quantified by the proportion of neu-
rons successfully reaching the CP after 4 days in utero
(Figures 3C and 3D). These results support the notion that
the function of ancestral SRGAP2 is conserved between
mouse and human and is inhibited by SRGAP2C expression
in vivo.
SRGAP2: A Postsynaptic Protein that Regulates Spine
Morphology In Vitro
The expression of SRGAP2C (up to P21) in neurons generated at
E15.5 did not alter the final position of neurons in layer 2/3Cell 149, 923–935, May 11, 2012 ª2012 Elsevier Inc. 927
Figure 3. SRGAP2C Expression in Radially Migrating Mouse Cortical Neurons Phenocopies Srgap2 Knockdown
(A) Confocal images of optically isolated neurons showing representative morphologies of radially migrating cortical neurons in E18.5 embryos following in utero
electroporation (IUE) at E14.5 of the indicated constructs. sh, short hairpin. Scale bar, 10 mm.
(B) Mean number of branches (±SEM) of the leading process of neurons as represented in (A). n = 3 animals/condition, 100–150 neurons/condition.
(C) Low magnification confocal images of E18.5 cortical slices showing migration of in utero electroporated neurons expressing nuclear-EGFP (nEGFP) alone or
together with SRGAP2A or SRGAP2C. Staining with anti-GFP shows the position of the electroporated neurons, and anti-NESTIN marks the radial glial scaffold.
dCP, dense Cortical Plate.
(D) Quantification of neuron distribution in cortical slices as illustrated in (C) (mean ±SEM). n = 3 animals/condition, 9–10 slices/condition.
In (B) and (D), *p < 0.05; **p < 0.01; ***p < 0.001; NS (not significant, p > 0.05); Mann-Whitney test. See also Figures S2 and S3.compared to control (Figure S3). Indeed, although SRGAP2C
expression was found to accelerate neuronal migration, this
is not expected to alter cell positioning in the context of inside-
out cortical neuron migration. The absence of an overt effect
on neuronal placement allowed us to address the potential func-
tion of SRGAP2 at later stages of brain development. We and
others have recently shown that SRGAP2 is highly expressed
in the mouse neocortex during the first weeks after birth (Bacon
et al., 2009; Guerrier et al., 2009), a period critical for spinogen-
esis and synaptogenesis in rodents (Miller, 1986; Romand et al.,
2011). Therefore, we decided to investigate the currently
unknown function of SRGAP2 in dendritic spines. In the
neocortex, spines receive most of the excitatory connections928 Cell 149, 923–935, May 11, 2012 ª2012 Elsevier Inc.and are a critical site of structural and functional synaptic plas-
ticity (Holtmaat and Svoboda, 2009; Yuste and Bonhoeffer,
2001). In mouse cortical neurons cultured for 20 days in vitro
(DIV), endogenous SRGAP2 showed a punctate staining that
was apposed to the presynaptic marker SYNAPSIN1 and ex-
tensively colocalized with the postsynaptic marker HOMER1
(Figure 4A), indicating that SRGAP2 is enriched at excitatory
synapses. Overexpression of mRFP-tagged SRGAP2 with
EGFP-tagged HOMER1c showed that SRGAP2 strongly accu-
mulates in the head of dendritic spines with HOMER1 clus-
ters (Figure 4B). Subcellular fractionation further con-
firmed that SRGAP2 is associated with synaptic membranes
and is detected in the postsynaptic density (Figure S4).
Figure 4. SRGAP2 Is Accumulated at Excitatory Synapses and Promotes Spine Head Growth in Cultured Cortical Neurons
(A) Segments of dendrites from cortical neurons (20 DIV) stained for SRGAP2 and the presynaptic marker SYNAPSIN1 (Syn) (left) or SRGAP2 and the excitatory
postsynaptic marker HOMER1 (right). Scale bar, 5 mm.
(B) When overexpressed, SRGAP2-mRFP localized to the head of dendritic spines and largely colocalized with the excitatory postsynaptic marker HOMER1c-
GFP. Note that SRGAP2 was barely detectable in spines with small HOMER1c clusters (arrowheads).
(C) Segments of dendrites from cortical neurons expressing a control shRNA (Control), an shRNA targetingmouseSrgap2 (shSrgap2) and shSrgap2 coexpressed
with SRGAP2A, which is resistant to this shRNA (rescue). Neurons were transfected 11 days after plating and imaged 9 days after transfection.
(D) Box plot showing the distribution of the width of spine heads in knockdown experiments. nControl = 1537, nshSrgap2 = 1261, nrescue = 910.
(E) Mean length of spine necks in knockdown experiments (±SEM).
(F) Segments of dendrites from cortical neurons expressing EGFP alone (control), or EGFP with ancestral SRGAP2 (SRGAP2). Neurons were transfected 17 to
18 days after plating and imaged 2 days after transfection.
(G) Distribution of the width of spine heads in gain-of-function experiments as illustrated in (F). nControl = 907 and nSRGAP2 = 1020.
(H) Mean length of spine necks in gain-of-function experiments (±SEM).
In (B), (C), and (F), scale bars, 2 mm. ***p < 0.001, NS: p > 0.05, Mann-Whitney test. Data are from aminimum of three independent experiments. See also Figures
S2 and S4.We next performed several loss- and gain-of-function experi-
ments and measured key parameters of spine morphology: (1)
the width of the spine head, which correlates with the size of
the postsynaptic density, the number of synaptic AMPA gluta-mate receptors, and the number of presynaptic vesicles (Are-
llano et al., 2007; Bourne and Harris, 2007; Harris and Stevens,
1989; Matsuzaki et al., 2004) and can be used as an indicator
of spine maturation (Harris and Stevens, 1989) and (2) the lengthCell 149, 923–935, May 11, 2012 ª2012 Elsevier Inc. 929
Figure 5. SRGAP2 Deficiency Delays Spine
Maturation and Increases Spine Density
In Vivo
(A) Representative western blot showing the rela-
tive amount of SRGAP2 in cortical lysates of wild-
type (WT), heterozygous (HET), and KO mice.
(B) Quantification of SRGAP2 level in cortical
lysates from three different animals per genotype
normalized (norm.) to b-actin and to the average
SRGAP2 level in WT.
(C–F) Dose-dependent effect of SRGAP2 defi-
ciency in juvenile mice (P18–P21). (C) Segments of
oblique dendrites from WT, HET, and KO mice
expressing YFP in layer 5 pyramidal neurons
(Thy1-YFP H line). (D) Distribution of spine head
widths, nWT = 1278, nHET = 1307, and nKO = 1602.
(E) Mean spine neck length (±SEM). (F) Mean spine
density (±SEM). nWT = 26, nHET = 20, and nKO = 28.
(G–J) Long-term effect of SRGAP2 deficiency on
dendritic spines. (G) Segments of oblique
dendrites from adult (P65–P77) WT, HET, and KO
mice expressing YFP in layer 5 pyramidal neurons
(Thy1-YFP H line). (H) Distribution of spine head
widths in adult neurons, nWT = 1394, nHET = 1441,
and nKO = 2010. (I) Mean spine neck length in adult
neurons (±SEM). (J) Mean spine density (±SEM).
nWT = 23, nHET = 23, and nKO = 35. Scale bars,
2 mm. ***p < 0.001, NS: p > 0.05, Mann-Whitney
test. See also Figure S5 and Table S2.of the spine neck, which impacts the biochemical and potentially
the electrical isolation of the spine head from the dendritic shaft
(Araya et al., 2006; Noguchi et al., 2005; Yuste, 2011). We first
studied SRGAP2 function in cultured cortical neurons by using
RNA interference (see Figure S2). Plasmids expressing a control
shRNA or shRNA against mouse Srgap2 (shSrgap2) were intro-
duced into neurons usingmagnetofection after 11 DIV, and spine
morphology was quantified 9 to 10 days later. Neurons express-
ing a control shRNA (Figure 4C) exhibited spines with an average
spine head width of 0.458 ± 0.004 mm (n = 1,377) (Figure 4D) and
an average neck length of 0.56 ± 0.01 mm (Figure 4E). shSrgap2-
expressing neurons displayed immature-looking spines (Fig-
ure 4C) with smaller head width (0.367 ± 0.004 mm, n = 1,139,
Figure 4D) and longer spine neck (87 ± 0.02 mm, Figure 4E)
than control shRNA-expressing neurons. We also observed an
increase in spine density from 1.25 ± 0.04 spine.mm1 in control
neurons (n = 15) to 2.14 ± 0.13 spine.mm1 in shSrgap2-express-
ing neurons (n = 15). The effects of SRGAP2 knockdown on spine
morphology and density could be rescued by coexpressing the
shRNA against Srgap2 with an shRNA-resistant cDNA (Figures
S2 and 4C–4E, density after rescue: 1.20 ± 0.06 spine.mm1,930 Cell 149, 923–935, May 11, 2012 ª2012 Elsevier Inc.n = 15). Conversely, in gain-of-function
experiments, overexpression of SRGAP2
for only 48 hr induced a striking enlarge-
ment of dendritic spines in 20 DIV
neurons, as visualized by cotransfection
with EGFP (Figure 4F). Upon SRGAP2
overexpression, most spines were mush-
room shaped, with larger spine heads
(Figure 4G) and shorter spine necks (Fig-ure 4H) than spines in control neurons. Interestingly, SRGAP2
was barely detected in long, thin spines but was strongly
accumulated in spines with large heads (see arrowheads in
Figure 4B). Altogether, these results suggest that SRGAP2
is a new postsynaptic protein that promotes spine head
enlargement.
SRGAP2 Promotes Spine Maturation and Limits Spine
Density in the Neocortex
To obtain further insights into the function of SRGAP2 in vivo, we
took advantage of a gene trap allele of Srgap2, hereafter called
Srgap2 KO (SRGAP2Gt(XH102)Byg/Mmcd, available at MMRRC-UC
Davis, Figures S5A–5C). Mapping of the insertion site in intron
2 by using an inverse PCR strategy allowed us to design
a PCR genotyping protocol to distinguish the heterozygous
mice from the homozygous mice (Figures S5A–5C). The homo-
zygous Srgap2 KO mice showed an 90% reduction in the level
of Srgap2 transcript (Figure S5D), as well as protein (Figures 5A–
5B) in the cortex, whereas heterozygous mice expressed inter-
mediate levels of Srgap2 mRNA and protein. Srgap2 KO mice
were viable (although born significantly below the expected
Figure 6. SRGAP2C Expression in Mouse Cortical Neurons Phenocopies SRGAP2 Deficiency in Spines
(A–C) SRGAP2C expression induces long, thin spines in cultured cortical neurons. (A) Segment of dendrites from cortical neurons (20 DIV) expressing EGFP alone
(Control), or EGFP and SRGAP2C (SRGAP2C). Neurons were imaged 2 days after transfection. (B) Box plot representing the distribution of the width of spine
heads. nControl = 907 (same as Figures 4F–4H) and nSRGAP2C = 1029. (C) Mean length of spine necks (±SEM).
(D–H) Effect of SRGAP2C expression in juvenile mice in layer 2/3 pyramidal neurons following in utero electroporation (IUE) at E15.5. (D) Representative layer 2/3
pyramidal neurons expressing a control cDNA (Control, left) or SRGAP2C (right) with a vector encoding mVenus. The white lines delineate the border of the
original images. (E) Segments of oblique dendrites from neurons in the conditions described above. (F) Distribution of spine head widths, nControl = 1068,
nSRGAP2C = 1167. (G) Mean spine neck length (±SEM). (H) Mean spine density (±SEM). nControl = 16 and nSRGAP2C = 16.
(I–L) Long-term effect of SRGAP2C expression on spines in adult mice. (I) Segments of oblique dendrites from control and SRGAP2C-expressing neurons after
IUE at E15.5. (J) Distribution of spine head widths, nControl = 800 and nSRGAP2C = 941. (K) Mean spine neck length (±SEM). (L) Mean spine density (±SEM).
nControl = 14 and nSRGAP2C = 12. Scale bars, 2 mm in (A), (E), and (I) and 50 mm in (D). ***p < 0.001, NS : p > 0.05, Mann-Whitney test. See also Figure S6.Mendelian ratio; see Table S2) and showed no abnormality in
cortical lamination (Figures S6A and 6B). Srgap2 KO mice were
crossedwith reporter mice expressing yellow fluorescent protein
(YFP) in layer 5 pyramidal neurons (Thy1-YFP line H; Feng et al.,
2000), allowing quantitative assessment of dendritic spine
morphology (Figure S6C). In juvenile mice (P18–P21), analysis
of spines in apical oblique dendrites (see arrows in Figure S6C)
of layer 5 pyramidal neurons from wild-type, heterozygous,
and homozygous KO mice (Figure 5C) revealed that SRGAP2deficiency decreased the width of spine heads (Figure 5D) and
increased the length of spine necks (Figure 5E), which is consis-
tent with the results obtained with cultured neurons. These
morphological defects were associated with a marked increase
in the density of dendritic spines (Figure 5F). Interestingly, these
changes were dose dependent. Indeed, in juvenile mice hetero-
zygous for Srgap2, spines were thinner, longer, and more
numerous than in wild-type mice, but to a lesser extent than in
KO mice (Figures 5C–5F).Cell 149, 923–935, May 11, 2012 ª2012 Elsevier Inc. 931
We then wondered whether these defects were transient or
maintained in adults. In adults (>P65 mice) (Figure 5G), the size
of spine heads in wild-type mice was in the same range as in
wild-type juveniles (Figures 5D and 5H), indicating that spines
were already morphologically mature at P21. This is consistent
with a previous report on the development of layer 5 pyramidal
neurons (Romand et al., 2011). In contrast, heterozygous and
KO neurons showed a substantial growth of their spine heads
between juvenile and adult stages (Figures 5D and 5H). We
observed a 22% and a 40% increase in the mean head width
in heterozygous and KO neurons, respectively, so that the size
of spine heads in these neurons was close to the valuemeasured
in wild-type neurons (Figure 5H) and even slightly larger (8% and
10% larger in heterozygous and KO neurons, respectively, and
see Figure S6D). These data strongly suggest that SRGAP2-
deficient neurons were still immature at P21 but eventually
reached maturation in adults. Importantly, adult SRGAP2-
deficient neurons maintained spines with longer necks and
a spine density 1.4-fold higher than in wild-type neurons
(Figures 5I and 5J). Taken together, these results indicate
that (1) SRGAP2 promotes spine maturation and limits spine
density in vivo and (2) SRGAP2 coregulates spine density
with the length of spine neck. Thus, at low SRGAP2 levels, the
phase of spinogenesis is extended, and adult neurons display
more numerous spines with longer necks, which may have
a profound impact on neuronal connectivity and synaptic input
integration.
Expression of Human-Specific SRGAP2C in Mouse
Neurons Delays Spine Maturation and Increases Spine
Number
Based on all the results shown so far, we hypothesized that long-
term expression of the human protein SRGAP2C would delay
spinematuration. In vitro,mousecortical neurons thatweremain-
tained for 20 DIV and analyzed 2 days posttransfection of
SRGAP2C displayed significant changes in spine morphology
(Figures 6A–6C). These changes were opposite to the overex-
pression of SRGAP2 (see Figures 4F–4H) and similar to the
shRNA-mediated knockdown of SRGAP2 (see Figures 4C–4E).
We next analyzed in juvenile mice the consequences of
SRGAP2C expression in layer 2/3 pyramidal neurons following
in utero electroporation at E15.5. The coexpression of myristoy-
lated Venus allowed the visualization of neuronal morphology
(Figure 6D). As expected, in juvenilemice, SRGAP2C-expressing
neurons exhibited numerous immature-looking spines as
compared to control neurons (Figure 6E). Spines in SRGAP2C-
expressing neurons had smaller head (Figure 6F), longer neck
(Figure 6G), and were present at a higher density (Figure 6H)
than in control neurons. In adult SRGAP2C-expressing neurons
(Figure 6I), spine headwidthswere similar to control neurons (Fig-
ure 6J), but both spine neck length (Figure 6K) and spine density
(Figure 6L) remained significantly higher than in control neurons.
Again, these effects were highly similar to what we observed in
SRGAP2-deficient layer 5 pyramidal neurons in vivo (Figures
5C–5J). Overall, these results show that expression of SRGAP2C
in the mouse neocortex leads to changes in spine development
that are compatible with an inhibition of endogenous SRGAP2
and result in neoteny during dendritic spine maturation.932 Cell 149, 923–935, May 11, 2012 ª2012 Elsevier Inc.DISCUSSION
Inhibition of SRGAP2 Function Leads to Sustained
Radial Migration
Our study is among the first to address the functional con-
sequence of human-specific gene duplication during brain
development. We show that the human-specific paralogs of
SRGAP2, along with the ancestral copy, are expressed in devel-
oping and adult neurons at the RNA and protein levels. The
SRGAP2 duplicates encode a truncated F-BAR domain that
binds to and antagonizes the function of ancestral SRGAP2
during neuronal migration and morphogenesis. We previously
showed that, in the mouse fetal brain, SRGAP2 is upregulated
at the end of cortical migration, at which point it promotes
branching in the leading process and decreases the rate of
migration (Guerrier et al., 2009). Here, we found that introduction
of human-specific SRGAP2C in utero in mouse pyramidal
neurons mimics SRGAP2 deficiency during neuronal migration,
leading to a deficit in branching in the leading process of
migrating neurons and allowing neurons to reach their final posi-
tion in the cortical plate faster than control neurons. We propose
that these effects of human-specific SRGAP2C expression may
underlie a more persistent form of radial migration and delay its
termination. This could support the journey of neurons over the
total thickness of the cortical wall, which is substantially
increased in humans as compared to nonhuman primates or
rodents (Dehay and Kennedy, 2007; Rakic, 2009; Sidman and
Rakic, 1973).
Temporal Control of Spine Development
Numerous proteins have been implicated in the formation,
maturation, and maintenance of spines (Bourne and Harris,
2008; Dillon and Goda, 2005; Elias et al., 2008; Hayashi
et al., 2009), but the mechanisms regulating the timing of
spine development in vivo remain poorly understood. In this
study, we demonstrate that SRGAP2 associates with the
postsynaptic density to promote spine maturation and limits
spine density in vivo. In contrast, SRGAP2 deficiency or
expression of SRGAP2C delays spine maturation and leads
to an increased density of spines with longer necks in the
neocortex. These results suggest that SRGAP2C-induced
neoteny extends the period of spine production with long-
term consequences on their morphology. This altered develop-
mental trajectory of spine maturation may reflect changes in
excitatory synaptic development. Other genes have been
shown to produce heterochrony during organ development
with critical consequences for limb morphogenesis (Dolle´
et al., 1993) or for the expansion of the neocortical surface
(Lui et al., 2011; Rakic, 2009), supporting the notion that slower
developmental processes might underlie increasingly complex
morphogenesis.
Studies that have quantitatively compared spine morphology,
spine density, and the developmental time course of spinogene-
sis between human and monkey or mouse have revealed that (1)
spinogenesis in prefrontal areas presents neoteny in humans
(Huttenlocher and Dabholkar, 1997; Petanjek et al., 2011); (2)
spine density in comparable neocortical areas and layers is
higher in humans (Benavides-Piccione et al., 2002; Elston
et al., 2001); and (3) there are substantial differences in spine
morphology between species, as human spines have longer
necks and larger heads than in the other species analyzed
(Benavides-Piccione et al., 2002). Our results suggest that
the human-specific duplication of SRGAP2 is involved in the
emergence of these differences. In the human brain, the rate of
spine development differs between cortical areas (Huttenlocher
and Dabholkar, 1997). Further investigations will test whether
expression of SRGAP2C shows spatial heterogeneity.
Functional Implications of Human-Specific SRGAP2
Duplication
Spines are known to enhance synaptic connectivity, enable
linear integration of synaptic inputs, and implement synapse-
specific plasticity (Yuste, 2011). The spine neck represents
a physical barrier between the synaptic contact in the spine
head and the dendritic shaft. The length of the neck impacts
the compartmentalization of synaptic signaling and the filtering
of synaptic inputs, whereas the volume of the spine head is
an indicator of the size of the postsynaptic density and the
strength of the synapse (Bourne and Harris, 2008; Yuste,
2011). Both the neck and the head of spines undergo morpho-
logical and functional plasticity (Bloodgood and Sabatini, 2005;
Matsuzaki et al., 2004; Yuste and Bonhoeffer, 2001), and spines
with a larger head and a wider, shorter neck have been observed
after induction of synaptic potentiation in rodents (Yuste and
Bonhoeffer, 2001). We found that SRGAP2 coregulates the
density of spines and the length of the spine neck. Accordingly,
SRGAP2-deficient neurons or SRGAP2C-expressing neurons
harbored spines with longer necks and higher spine density.
In our experiments, spine heads in adult SRGAP2-deficient
neurons were comparable in size to wild-type neurons. In this
context, we speculate that expression of SRGAP2C might allow
human cortical pyramidal neurons to receive and integrate
a significantly higher number of synaptic inputs without satura-
tion. Such morphological features have been proposed to
introduce more opportunities and more flexibility for input inte-
gration and information processing in human cortical circuits
(Benavides-Piccione et al., 2002). On the other hand, expression
of SRGAP2 might also contribute to the higher susceptibility
to neurodegenerative or psychiatric disorders of the human
brain (Konopka et al., 2009).
Taken together, our results suggest that the expression of
SRGAP2C in the human brain inhibits the function of ancestral
SRGAP2 and thereby reduces the rate of spine maturation,
leading to changes in spine morphology and density that could
have important implications for cognition, learning, andmemory.
SRGAP2 is both a membrane-binding protein and a Rho-GAP
for the small GTPase Rac1, which has been associated with
neurodevelopmental disorders (Govek et al., 2005). It will be
important to address the molecular mechanisms by which
SRGAP2 promotes spine maturation and to address how
SRGAP2C interferes with this process. A large genomic alter-
ation affecting the human ancestral SRGAP2A gene has recently
been reported in a patient with early-infantile encephalopathy
with associated epilepsy (Saitsu et al., 2011). However, this
study was based on a single patient presenting a large chromo-
somal translocation that affected the expression of SRGAP2A,as well as other genes. Future investigations will test whether
alterations in copy number or sequence variation of ancestral
SRGAP2A or its human-specific paralogs underlie neurodeve-
lopmental or cognitive defects, such as autism spectrum disor-
ders or schizophrenia.
EXPERIMENTAL PROCEDURES
Constructs
Human SRGAP2A (GenBank BC132874) and SRGAP2C (GenBank
BC112927) cDNA were obtained from the IMAGE consortium. cDNA encoding
SRGAP2B was a gift from the Eichler laboratory. See Extended Experimental
Procedures for details of constructs used in this paper.
RNA In Situ Hybridization
The human fetal material (GW11) used to perform in situ hybridization was
collected and used according to the guidelines of the three relevant local
ethics committees on research involving human subjects (Erasme Academic
Hospital, University of Brussels, and Belgian National Fund for Scientific
Research). Written informed consent was given by the parents in each case.
Exon 22 of SRGAP2A (3316-4271 base pairs [bp] of BC132874) and intron 9
(1992-3128 bp of BC112927) were amplified and cloned into pGEM-T Easy
Vector System 1 (Promega), and they served as templates for generating
RNA in situ probes. In situ hybridization on human embryonic brain samples
was performed as previously described (Lambert et al., 2011).
Animals
All animals were handled according to protocols approved by the institutional
animal care and use committee (IACUC) at the University of North Carolina at
Chapel Hill and The Scripps Research Institute, La Jolla. For timed pregnant
matings, noon after mating is considered embryonic day 0.5 (E0.5). Juveniles
correspond to mice between postnatal day (P) 18 and P21, and adults corre-
spond to mice between P65 and P77. For information regarding genetic
strains, refer to Extended Experimental Procedures.
In Utero Electroporation
We performed in utero electroporation as per a previously described protocol
(Yi et al., 2010). Endotoxin-free plasmid DNA was injected at a concentration
of 1 mg/ml in the lateral ventricles. In case of coelectroporation, we injected
equimolar quantities of the two plasmids to ensure coexpression. Please
see Extended Experimental Procedures for electroporation settings, tissue
preparation, slicing, and immunostaining of electroporated brains.
Primary Neuronal Culture, Magnetofection, and
Immunocytochemistry
Primary cultures of cortical neurons were prepared from embryonic BALB/c
mice at days 17.5–18.5 and transfection was performed by magnetofection
using NeuroMag (OZ Bioscience) according to the manufacturer’s protocol
at the indicated times. See details in Extended Experimental Procedures.
Morphometric Analysis of Spines
Morphometric analyses of dendritic spines were performed on z-projections
for cultured neurons and in the depth of the z stack for slices using NIS-
Elements (Nikon imaging software). Head width was defined as the largest
length of the head that was perpendicular to the neck. Neck length was
measured from the point of attachment of the dendrite to the beginning of
the spine head, as estimated by the investigator. When the neck could not
be distinguished from the head, the neck length was considered to be zero.
When the neck was not clearly visible, it was considered to be the shortest
distance between the base of the head and the closest surface of the dendrite.
Only spines arising from the lateral surfaces of the dendrites were taken into
account. For analyses in slices, spines were quantified in the proximal part
of oblique dendrites directly originating from the apical trunk. Spines were
quantified over an average of 60 mm of dendrite in juvenile mice and 40 mm
in adult mice. Spine density was defined as the number of quantified spines
divided by the length over which the spines were quantified. The length ofCell 149, 923–935, May 11, 2012 ª2012 Elsevier Inc. 933
the dendritic segment was measured on the z projection, which implies that
the density could be overestimated. To limit this issue, only dendrites that
were parallel to the plane of the slice were analyzed. Spine analysis in vivo
was analyzed in brain sections of comparable rostro-caudal position. See
Extended Experimental Procedures for more details.
Subcellular Fractionation
Subcellular fractionation was performed from P15 mouse brains as described
in Pe´rez-Otan˜o et al. (2006) with minor modifications. See Extended Experi-
mental Procedures for details of antibodies used.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures,
six figures, and two tables and can be found with this article online at
doi:10.1016/j.cell.2012.03.034.
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